CRVS

CORVUS PHARMACEUTICALS INC

CRVS·221015100·US·Common Stock·Healthcare - Biotechnology-Activist

CRVS (CORVUS PHARMACEUTICALS INC) is held by 93 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($106.7M), STATE STREET CORP ($66.8M), PRICE T ROWE ASSOCIATES INC /MD/ ($56.6M). Net institutional sentiment: Bullish.

93
Holders
(7 Elite)
$586.1M
Total Value
67% (98)
Consensus
66 buying - 32 selling
13F: Insider & Congress: Updated regularly
CRVS

Smart Money Verdict

View all
Loading verdict
Held by 93 funds
7 elite

Who's Trading

Source dates: Price Oct 12, 2026 · Insiders Jun 15, 2026 · Activists Aug 7, 2026 · Congress none

ActivistSTATE STREET CORPORATIONSTATE STREET CORPORATION5.3%Aug 7, 2026
ActivistBlackRock, Inc.BlackRock, Inc.7.5%Jul 27, 2026
InsiderMSMoore David ScottBuy $250KJun 11, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
7.1M(+15.9%)$106.7M0.0%+23.86%
35
Increased
4.5M(+25.5%)$66.8M0.0%+3.59%
36
Increased
3.8M(+29.9%)$56.6M0.0%-31.22%
37
Increased
3.3M(+1.8%)$49.2M0.0%-42.52%
30
Increased
2.7M(+17.8%)$40.8M0.0%-36.48%
34
Increased
1.9M(+8.2%)$27.7M0.0%+54.22%
31
Increased
1.6M(+2.3%)$23.6M0.0%-15.16%
29
Increased
1.6M(+17.7%)$23.5M0.2%-41.37%
40
Decreased
1.3M(-46.2%)$20.1M0.0%+50.05%
0
Increased
1M(+21.0%)$15.7M0.0%-4.13%
34
Increased
814,750(+21.6%)$12.2M0.0%-41.12%
33
Increased
785,208(+45.4%)$11.7M0.0%-28.87%
38
Increased
757,798(+219.7%)$11.3M0.0%-17.28%
45
Unchanged
750,000$11.2M0.0%-42.67%
0
Increased
575,158(+13.6%)$8.6M0.0%+38.46%
31
Increased
520,528(+3.1%)$7.8M0.0%-42.41%
28
Unchanged
450,000$6.7M0.1%-42.67%
0
Decreased
397,951(-10.1%)$5.9M0.0%-21.40%
0
Increased
396,116(+37.0%)$5.9M0.0%-5.58%
35
Increased
315,749(+29.5%)$4.7M0.0%+39.37%
34

Showing 1-20 of 103

1 / 6
CRVSCRVSCORVUS PHARMACEUTICALS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used